首页> 外文期刊>Drug development and industrial pharmacy >Development of chitosan/gelatin/keratin composite containing hydrocortisone sodium succinate as a buccal mucoadhesive patch to treat desquamative gingivitis
【24h】

Development of chitosan/gelatin/keratin composite containing hydrocortisone sodium succinate as a buccal mucoadhesive patch to treat desquamative gingivitis

机译:含壳聚糖/明胶/角蛋白复合材料的开发含氢化氨酸琥珀酸钠作为口腔粘膜粘附贴剂,以治疗脱皮牙龈炎

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of this research was to develop chitosan/gelatin/keratin composite containing hydrocortisone sodium succinate as a buccal mucoadhesive patch to treat desquamative gingivitis, which was fabricated through an environmental friendly process. Mucoadhesive films increase the advantage of higher efficiency and drug localization in the affected region. In this research, mucoadhesive films, for the release of hydrocortisone sodium succinate, were prepared using different ratios of chitosan, gelatin and keratin. In the first step, chitosan and gelatin proportions were optimized after evaluating the mechanical properties, swelling capacity, water uptake, stability, and biodegradation of the films. Then, keratin was added at different percentages to the optimum composite of chitosan and gelatin together with the drug. The results of surface pH showed that none of the samples were harmful to the buccal cavity. FTIR analysis confirmed the influence of keratin on the structure of the composite. The presence of a higher amount of keratin in the composite films resulted in high mechanical, mucoadhesive properties and stability, low water uptake and biodegradation in phosphate buffer saline (pH = 7.4) containing 104 U/ml lysozyme. The release profile of the films ascertained that keratin is a rate controller in the release of the hydrocortisone sodium succinate. Finally, chitosan/gelatin/keratin composite containing hydrocortisone sodium succinate can be employed in dental applications.
机译:该研究的目的是开发含有氢化氨酸酸钠琥珀酸钠作为颊粘膜粘附贴剂的壳聚糖/明胶/角蛋白复合材料,以治疗脱皮牙龈炎,这是通过环保过程制造的。粘膜粘附膜增加了受影响地区效率和药物定位的优势。在该研究中,使用壳聚糖,明胶和角蛋白的不同比例制备粘膜粘附膜的粘膜粘附膜。在第一步中,在评估薄膜的机械性能,溶胀容量,水吸收,稳定性和生物降解后,优化了壳聚糖和明胶比例。然后,以不同的百分比加入角蛋白,与壳聚糖和明胶的最佳复合材料与药物不同。表面pH的结果表明,没有一个样品对颊腔有害。 FTIR分析证实了角蛋白对复合材料结构的影响。在复合膜中存在较高量的角蛋白,导致含有104U / mL溶菌酶104U / mL溶菌酶的磷酸盐缓冲盐水(pH = 7.4)中的机械,粘膜粘附性和稳定性,低水吸收和生物降解。薄膜的释放轮廓确定角蛋白是氢化碳酸钠释放中的速率控制器。最后,含有氢化鞘酸钠琥珀酸钠的壳聚糖/明胶/角蛋白复合材料可用于牙科应用。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号